Stock of Avalo Therapeutics, Inc. (AVTX) is rising about 38 percent in Wednesday morning trading after the company priced an offering of 250 million shares of common stock and pre-funded warrants at a combined price of $1.50 per share.
The company's shares are currently trading at $22.42 on the Nasdaq, up 38.13 percent. The stock opened at $22.80 and has climbed as high as $23.71 so far in today's session. Over the past year, it has traded in a range of $3.39 to $23.71.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.